Assembly Biosciences Inc. (ASMB)
NASDAQ: ASMB
· Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT
Assembly Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 23.62M | 32.15M | 28.52M | 28.33M | 21.48M | 12.95M | 7.16M | n/a | n/a | n/a | n/a | n/a | 6.25M | 6.25M | 6.25M | 7.29M | 35.65M | 75.02M |
Cost of Revenue | 64K | 96K | 128K | 148K | 264K | 358K | 450K | 490K | 508K | 502K | 498K | 494K | 18.83M | 18.83M | 18.82M | 46.72M | 55.19M | 78.4M |
Gross Profit | 23.59M | 32.09M | 28.42M | 28.18M | 21.22M | 12.59M | 6.71M | -490K | -508K | -502K | -498K | -494K | -12.58M | -12.58M | -12.57M | -39.43M | -19.54M | -3.37M |
Operating Income | -43.52M | -44.63M | -45.42M | -46.44M | -50.53M | -55.82M | -64.65M | -75.07M | -83.43M | -90.51M | -94.11M | -134.03M | -129.5M | -128.59M | -132.69M | -109.44M | -94.58M | -64.34M |
Interest Income | 3.59M | 5.04M | 5.57M | 6.07M | 5.36M | 4.49M | 3.45M | 2.41M | 2.04M | 1.56M | 1.02M | 540K | 356K | 315K | 302K | 425K | 1.02M | 1.64M |
Pretax Income | -39.04M | -39.59M | -39.85M | -40.37M | -45.17M | -51.32M | -61.2M | -72.66M | -81.39M | -88.95M | -93.09M | -133.49M | -129.14M | -128.28M | -132.39M | -109.02M | -93.56M | -62.7M |
Net Income | -38.96M | -39.92M | -40.18M | -40.8M | -45.61M | -51.35M | -60.62M | -71.29M | -79.75M | -87.21M | -91.89M | -130.51M | -126.43M | -125.67M | -129.85M | -109.02M | -93.56M | -62.7M |
Selling & General & Admin | 18M | 17.85M | 17.94M | 21.96M | 21.9M | 22.42M | 22.82M | 20.33M | 21.37M | 23.19M | 24.13M | 24.51M | 25.9M | 26.03M | 28.78M | 29.45M | 34.48M | 37.03M |
Research & Development | 58.77M | 58.91M | 55.93M | 52.66M | 49.97M | 46.23M | 48.9M | 54.75M | 62.05M | 67.32M | 69.98M | 67.87M | 68.22M | 67.17M | 68.52M | 87.29M | 95.75M | 102.33M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 76.77M | 76.75M | 73.88M | 74.62M | 71.86M | 68.65M | 71.72M | 75.07M | 83.43M | 90.51M | 94.11M | 92.39M | 94.11M | 93.21M | 97.3M | 116.73M | 130.23M | 139.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -32K | -64K | -148K | -148K | -116K | -84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 56.18M | 76.91M | 74.07M | 74.77M | 72.01M | 68.76M | 71.81M | 75.07M | 83.43M | 90.51M | 94.11M | 92.39M | 94.11M | 93.21M | 97.3M | 116.73M | 130.23M | 139.36M |
Income Tax Expense | -76K | 330K | 318.72K | 427.72K | 311.72K | -90.36K | -688.09K | -1.49M | -1.63M | -1.74M | -1.21M | -2.97M | -2.71M | -2.6M | -2.53M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7.66M | 7.51M | 6.58M | 6.35M | 5.64M | 5.48M | 5.48M | 4.38M | 4.36M | 4.25M | 4.07M | 48.45M | 48.29M | 48.12M | 44.95M | 45.57M | 42.88M | 39.68M |
Shares Outstanding (Diluted) | 7.66M | 7.51M | 6.58M | 6.35M | 5.64M | 5.48M | 5.48M | 4.38M | 4.36M | 4.25M | 4.07M | 48.45M | 48.29M | 48.12M | 45.57M | 45.57M | 42.88M | 39.68M |
EPS (Basic) | -5.73 | -6.38 | -6.87 | -7.15 | -8.93 | -10.83 | -13.48 | -16.8 | -13.98 | -10.6 | -6.77 | -2.79 | -2.73 | -2.78 | -2.99 | -2.64 | -2.32 | -1.56 |
EPS (Diluted) | -5.73 | -6.38 | -6.87 | -7.15 | -8.93 | -10.83 | -13.48 | -16.8 | -13.98 | -10.6 | -6.77 | -2.77 | -2.71 | -2.76 | -2.97 | -2.64 | -2.32 | -1.58 |
EBITDA | -43.42M | -44.5M | -45.29M | -46.26M | -50.27M | -55.46M | -64.2M | -74.58M | -83.05M | -90.03M | -93.64M | -89.16M | -84.52M | -83.72M | -87.83M | -108.56M | -93.68M | -63.43M |
EBIT | -42.63M | -44.63M | -45.42M | -46.44M | -50.53M | -55.82M | -64.65M | -74.49M | -82.84M | -89.82M | -93.42M | -92.28M | -87.75M | -86.95M | -91.05M | -109.22M | -94.36M | -63.42M |
Depreciation & Amortization | 98K | 130K | 129K | 181K | 264K | 358K | 450K | 490K | 508K | 502K | 498K | 494K | 479K | 479K | 466K | 660K | 681K | 683K |